Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 May;61(5):675–680. doi: 10.1038/bjc.1990.153

In vitro beta 2-microglobulin (beta 2m) secretion by normal and leukaemic B-cells: effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore.

R A Jones 1, H G Drexler 1, S M Gignac 1, J A Child 1, C S Scott 1
PMCID: PMC1971599  PMID: 2110813

Abstract

Due to the increasing therapeutic use of immunoregulatory agents and the potential effects on cellular function, we examined the modulation of in vitro beta 2-microglobulin (beta 2m) production rates by 'normal' tonsil and leukaemic B-cells in response to a number of these agents. Tonsil B-cells responded to phorbol ester (TPA) by an increased beta 2m production rate, which was further enhanced by the combined stimuli of TPA plus the calcium ionophore A23187. In marked contrast, however, lymphocytes from a majority (8/11) of B-cell malignancies showed a suppression of the TPA-induced beta 2m production rate in response to the combined TPA/A23187 stimulus. These different responses of 'normal' and malignant B-cells were not apparent when IgM production rates were examined. The recombinant cytokines IL-1, IL-2, IFN-alpha, IFN-gamma and TNF also enhanced beta 2m production rates of both normal and leukaemic B-cells, but to a considerably lesser extent than did TPA. Bryostatin-1 increased beta 2m production to a level intermediate between that obtained by TPA and the cytokines. It is suggested that beta 2m production rates may correspond to the degree of B-cell differentiation, and/or to the degree of cellular 'activation'. The results further indicate that the in vitro measurement of beta 2m production provides a different index of the cellular response than that obtained by the conventional measurement of IgM production.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bataille R., Grenier J. Serum beta 2 microglobulin in multiple myeloma. A critical review. Eur J Cancer Clin Oncol. 1987 Dec;23(12):1829–1832. doi: 10.1016/0277-5379(87)90047-2. [DOI] [PubMed] [Google Scholar]
  2. Beiske K., Clark E. A., Holte H., Ledbetter J. A., Smeland E. B., Godal T. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets. Int J Cancer. 1988 Oct 15;42(4):521–528. doi: 10.1002/ijc.2910420409. [DOI] [PubMed] [Google Scholar]
  3. Bertoglio J. H. Monocyte-independent stimulation of human B lymphocytes by phorbol myristate acetate. J Immunol. 1983 Nov;131(5):2279–2281. [PubMed] [Google Scholar]
  4. Blumberg P. M. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res. 1988 Jan 1;48(1):1–8. [PubMed] [Google Scholar]
  5. Campana D., Janossy G. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia. Blood. 1986 Dec;68(6):1264–1271. [PubMed] [Google Scholar]
  6. Child J. A., Kushwaha M. R. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases. Hematol Oncol. 1984 Oct-Dec;2(4):391–401. doi: 10.1002/hon.2900020409. [DOI] [PubMed] [Google Scholar]
  7. Conway T. P., Poulik M. D. Beta 2-microglobulin of lymphocytes. Adv Exp Med Biol. 1976;73(Pt B):87–92. [PubMed] [Google Scholar]
  8. Cresswell P., Springer T., Strominger J. L., Turner M. J., Grey H. M., Kubo R. T. Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A. 1974 May;71(5):2123–2127. doi: 10.1073/pnas.71.5.2123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation. 1984 Sep;38(3):287–292. doi: 10.1097/00007890-198409000-00018. [DOI] [PubMed] [Google Scholar]
  10. Drexler H. G., Brenner M. K., Coustan-Smith E., Gignac S. M., Hoffbrand A. V. Analysis of signal transduction in B chronic lymphocytic leukemia cells. Blood. 1988 May;71(5):1461–1469. [PubMed] [Google Scholar]
  11. Drexler H. G., Gignac S. M., Jones R. A., Scott C. S., Pettit G. R., Hoffbrand A. V. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood. 1989 Oct;74(5):1747–1757. [PubMed] [Google Scholar]
  12. Genot E., Billard C., Sigaux F., Mathiot C., Degos L., Falcoff E., Kolb J. P. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma. Leukemia. 1987 Aug;1(8):590–596. [PubMed] [Google Scholar]
  13. Jones R. A., Master P. S., Child J. A., Roberts B. E., Scott C. S. Diagnostic differentiation of chronic B-cell malignancies using monoclonal antibody L161 (CD1c). Br J Haematol. 1989 Jan;71(1):43–46. doi: 10.1111/j.1365-2141.1989.tb06272.x. [DOI] [PubMed] [Google Scholar]
  14. Melo J. V., Catovsky D., Galton D. A. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986 Jun;63(2):377–387. [PubMed] [Google Scholar]
  15. Nilsson K., Evrin P. E., Welsh K. I. Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev. 1974;21(0):53–84. doi: 10.1111/j.1600-065x.1974.tb01546.x. [DOI] [PubMed] [Google Scholar]
  16. Peterson P. A., Rask L., Lindblom J. B. Highly purified papain-solubilized HL-A antigens contain beta2-microglobulin. Proc Natl Acad Sci U S A. 1974 Jan;71(1):35–39. doi: 10.1073/pnas.71.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pfizenmaier K., Scheurich P., Schlüter C., Krönke M. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J Immunol. 1987 Feb 1;138(3):975–980. [PubMed] [Google Scholar]
  18. Plesner T. Immunochemical studies of human beta 2-microglobulin. A review of recent methodological progress and clinical applications. Allergy. 1980 Dec;35(8):627–637. doi: 10.1111/j.1398-9995.1980.tb02015.x. [DOI] [PubMed] [Google Scholar]
  19. Quesada J. R., Gutterman J. U., Hersh E. M. Treatment of hairy cell leukemia with alpha interferons. Cancer. 1986 Apr 15;57(8 Suppl):1678–1680. doi: 10.1002/1097-0142(19860415)57:8+<1678::aid-cncr2820571308>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  20. Robèrt K. H., Juliusson G., Einhorn S., Biberfeld P., Gahrton G. Activation of malignant B-lymphocytes: pathophysiologic and clinical importance. Scand J Haematol. 1986 Nov;37(5):363–370. doi: 10.1111/j.1600-0609.1986.tb02623.x. [DOI] [PubMed] [Google Scholar]
  21. Simonsson B., Danersund A., Tötterman T. H., Nilsson K., Wibell L. Production of beta 2-microglobulin by chronic lymphocytic leukaemia cells in vitro. Scand J Haematol. 1986 May;36(5):424–429. doi: 10.1111/j.1600-0609.1986.tb02276.x. [DOI] [PubMed] [Google Scholar]
  22. Simonsson B., Wibell L., Nilsson K. Beta 2-microglobulin in chronic lymphocytic leukaemia. Scand J Haematol. 1980 Feb;24(2):174–180. doi: 10.1111/j.1600-0609.1980.tb02364.x. [DOI] [PubMed] [Google Scholar]
  23. Späti B., Child J. A., Kerruish S. M., Cooper E. H. Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study. Acta Haematol. 1980;64(2):79–86. doi: 10.1159/000207215. [DOI] [PubMed] [Google Scholar]
  24. Swanson R. A., Tracy R. P., Katzmann J. A., Wilson D. M., Young D. S. Beta 2-microglobulin determined by radioimmunoassay with monoclonal antibody. Clin Chem. 1982 Oct;28(10):2033–2039. [PubMed] [Google Scholar]
  25. Tötterman T. H., Nilsson K., Simonsson B. Phorbol ester-induced production of beta-2-microglobulin in B-CLL cells: relation to IgM secretory response and disease activity. Br J Haematol. 1986 Jan;62(1):95–103. doi: 10.1111/j.1365-2141.1986.tb02904.x. [DOI] [PubMed] [Google Scholar]
  26. Wallach D., Fellous M., Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature. 1982 Oct 28;299(5886):833–836. doi: 10.1038/299833a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES